These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 20851941

  • 1. Staging monoclonal plasma cell disease: comparison of the Durie-Salmon and the Durie-Salmon PLUS staging systems.
    Fechtner K, Hillengass J, Delorme S, Heiss C, Neben K, Goldschmidt H, Kauczor HU, Weber MA.
    Radiology; 2010 Oct; 257(1):195-204. PubMed ID: 20851941
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of whole-body diffusion MRI and conventional radiological assessment in the staging of myeloma.
    Narquin S, Ingrand P, Azais I, Delwail V, Vialle R, Boucebci S, Tasu JP.
    Diagn Interv Imaging; 2013 Jun; 94(6):629-36. PubMed ID: 23683788
    [Abstract] [Full Text] [Related]

  • 5. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
    D'Anastasi M, Notohamiprodjo M, Schmidt GP, Dürr HR, Reiser MF, Baur-Melnyk A.
    AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
    [Abstract] [Full Text] [Related]

  • 6. Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging.
    Bäuerle T, Hillengass J, Fechtner K, Zechmann CM, Grenacher L, Moehler TM, Christiane H, Wagner-Gund B, Neben K, Kauczor HU, Goldschmidt H, Delorme S.
    Radiology; 2009 Aug; 252(2):477-85. PubMed ID: 19703885
    [Abstract] [Full Text] [Related]

  • 7. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
    Kloth JK, Hillengass J, Listl K, Kilk K, Hielscher T, Landgren O, Delorme S, Goldschmidt H, Kauczor HU, Weber MA.
    Int J Cancer; 2014 Nov 15; 135(10):2380-6. PubMed ID: 24706394
    [Abstract] [Full Text] [Related]

  • 8. Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma.
    Dutoit JC, Vanderkerken MA, Verstraete KL.
    Eur J Radiol; 2013 Sep 15; 82(9):1444-52. PubMed ID: 23726124
    [Abstract] [Full Text] [Related]

  • 9. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
    Sezer O, Heider U, Zavrski I, Possinger K.
    Haematologica; 2001 Aug 15; 86(8):837-43. PubMed ID: 11522540
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Whole-body MRI of multiple myeloma: comparison of different MRI sequences in assessment of different growth patterns.
    Weininger M, Lauterbach B, Knop S, Pabst T, Kenn W, Hahn D, Beissert M.
    Eur J Radiol; 2009 Feb 15; 69(2):339-45. PubMed ID: 18096344
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
    Conté L G, Figueroa M G, Lois V V, Cabrera C ME, León R A, García L H, Rojas R H.
    Rev Med Chil; 2008 Jan 15; 136(1):7-12. PubMed ID: 18483648
    [Abstract] [Full Text] [Related]

  • 15. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system.
    Durie BG.
    Eur J Cancer; 2006 Jul 15; 42(11):1539-43. PubMed ID: 16777405
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma cell proliferation in monoclonal gammopathy: relations with other biologic variables--diagnostic and prognostic significance.
    Ffrench M, Ffrench P, Remy F, Chapuis-Cellier C, Wolowiec D, Ville D, Bryon PA.
    Am J Med; 1995 Jan 15; 98(1):60-6. PubMed ID: 7825620
    [Abstract] [Full Text] [Related]

  • 18. [Long-term survival and prognostic factors in stage II-III multiple myeloma treated with conventional chemotherapy].
    Pertuiset E, Chevret S, Lioté F, Delauche MC, Bardin T, Dryll A, Kuntz D.
    Ann Med Interne (Paris); 1992 Jan 15; 143(8):519-24. PubMed ID: 1303595
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.